Pola Peresepan Anak dengan Infeksi Saluran Pernapasan Akut (ISPA) Non Pneumonia di Klinik

  • Rini Sasanti Handayani Puslitbang Sumber Daya dan Pelayanan Kesehatan Bdan Litbangkes Kemenkes, Jakarta, Indonesia
  • Ida Diana Sari Puslitbang Sumber Daya dan Pelayanan Kesehatan Bdan Litbangkes Kemenkes, Jakarta, Indonesia
  • Nita Prihartini Puslitbang Sumber Daya dan Pelayanan Kesehatan Bdan Litbangkes Kemenkes, Jakarta, Indonesia
  • Yuyun Yuniar Puslitbang Sumber Daya dan Pelayanan Kesehatan Bdan Litbangkes Kemenkes, Jakarta, Indonesia
  • Retno Gitawati Puslitbang Sumber Daya dan Pelayanan Kesehatan Bdan Litbangkes Kemenkes, Jakarta, Indonesia
Keywords: ARI, Children, Clinics, Rational, Prescribing

Abstract

Acute respiratory infection (ARI) is a common disease in the community. Riskesdas 2018 stated that ARI prevalence was 4.4% and the highest was in 1-4 years old children (8%). The capitation payment system in clinics collaborated with BPJS Kesehatan demands the physician to prescribe as effective and as efficient as possible. On the other hand, the capitation tariff obtained by clinics is considered as too low, thus constrains of the prescription leading to irrational prescribing is likely to occur. This study analyses further the prescribing pattern for ARI children in clinics and its rationality based on the difference in source of funding. A cross sectional research using retrospective method was conducted. Data were gathered from 409 medical records and or patients’ prescription of children between 1-12 years old and diagnosed as having non pneumonia ARI during 1st January to 30th November 2019. Result showed that non pneumonia ARI patients were mostly boys (54,3%) aged 1-5 years old (6.0%). The average number of items for BPJS patients was 3,45, the percentage of generic prescribing was twofold higher for BPJS group (63.94%), the percentage of essential medicine prescribing was 63.96% while the percentage of antibiotic use was lower (48.50%). Dosage propriety for BPJS patients was 70.80% which was slightly higher than non-BPJS group. Overall, the prescribing indicators and dosage properness for BPJS patients were better than non-BPJS patients.

References

Wijayaningsih KS. Asuhan keperawatan anak sakit. Jakarta: Trans Info Media; 2013.

Badan Penelitian dan Pengembangan Kesehatan. Laporan nasional RISKESDAS 2018 [Internet]. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2018 [disitasi 2021 Jan 7]. diperoleh dari: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf

WHO. Pedoman interim WHO: Pencegahan dan pengendalian infeksi saluran pernafasan akut (ISPA) yang cenderung menjadi epidemi dan pandemi di fasilitas pelayanan kesehatan. Jenewa: World Health Organization; 2008. p. 100.

Republik Indonesia. Peraturan Menteri Kesehatan Nomor 5 Tahun 2014 tentang Pedoman Praktik Klinis bagi Dokter di Fasilitas Kesehatan Primer [Internet]. Jakarta: Kementerian Kesehatan; 2015 [disitasi 2021 Jan 7]. Diperoleh dari: http://weekly.cnbnews.com/news/article.html?no=124000

Ismawardani D, Novelia E, Nurcahyo C, Yuliasman, Ramdhani J, Setiawan B, et al. Info BPJS Kesehatan: Faskes tingkat pertama tangani 144 penyakit. Edisi XI. Jakarta: BPJS Kesehatan; 2014. p. 7.

Republik Indonesia. Peraturan Badan Penyelenggara Jaminan Sosial Kesehatan Nomor 2 Tahun 2015 tentang Norma Penetapan Besaran Kapitasi dan Pembayaran Kapitasi Berbasis Pemenuhan Komitmen Pelayanan pada Fasilitas Kesehatan Tingkat Pertama. Jakarta: BPJS Kesehatan; 2015.

Farmalkes Kementerian Kesehatan RI. Modul penggunaan obat rasional. Jakarta: Kementerian Kesehatan RI; 2020 Nov 24.

Republik Indonesia. Peraturan Menteri Kesehatan Nomor 9 Tahun 2014 tentang Klinik. Jakarta: Kementerian Kesehatan; 2014.

Pusat Data dan Informasi Kementerian Kesehatan Republik Indonesia. Data dan informasi profil kesehatan Indonesia 2018 [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2018. Diperoleh dari https://pusdatin.kemkes.go.id/folder/view/01/structure-publikasi-data-pusat-data-dan-informasi.html

Badan Penelitian dan Pengembangan Kesehatan. Laporan survei indikator kesehatan nasional (Sirkesnas) 2016. Jakarta: Kementerian Kesehatan Republik Indonesia; 2016.

Sasanti HR. Laporan rifaskes tematik studi penggunaan obat di rumah sakit dan klinik. Jakarta: Badan Litbang Kesehatan; 2019.

Maakh YF, Laning I, Tattu R. Profil pengobatan infeksi saluran pernapasan akut (ISPA) pada balita di Puskesmas Rambangaru tahun 2015. Jurnal Info Kesehatan. 2017;15(2):435–50.

Sholihah NM, Susanti R, Untari EK. Gambaran pengobatan dan biaya medis langsung pasien ispa anak Di Rs ‘X’ Tahun 2015. Jurnal Manajemen dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice. 2017;7(1):40.

Grassella, Yuswar MA, Purwanti NU. Studi rasionalitas penggunaan antibiotik dan interaksi obat pada pasien anak terdiagnosis infeksi saluran pernafasan akut (ISPA) di instalasi rawat jalan RSUD Sultan Syarif Mohamad Alkadrie Pontianak tahun 2018. Jurnal Mahasiswa Farmasi Fakultas Kedokteran Universitas Tanjungpura. 2018;4–17.

Jadhav S, Khanwelkar C. Prescribing pattern of drugs in acute respiratory tract infection in children aged 1 to 5 years at tertiary care teaching hospital. Biomedical and Pharmacology Journal. 2018;11(4):1903–11.

Zoorob R, Sidani MA, Fremont RD, Kihlberg C. Antibiotic use in acute upper respiratory tract infections. American Family Physician. 2012;86(9):817–22.

Putra IMAS, Wardani IGAAK. Profil penggunaan antibiotika untuk pengobatan ISPA nonpneumonia di Puskesmas Kediri II tahun 2013 sampai dengan 2015. Jurnal Ilmiah Medicamento. 2017;3(1):1–6.

Sauriasari R, Azka A, Aulia H, Swastika A. Evaluasi kesesuaian penulisan resep pada kasus ISPA non pneumonia di poli MTBS Puskesmas Kecamatan Cengkareng. Pharmaceutical Sciences and Research. 2017;4(2):81–7.

Holloway KA. Indonesia: Pharmaceuticals in health care delivery mission report 10-23 July 2011. New Delhi: WHO Regional Office for South East Asia; 2011.

Mensa M, Tadesse T, Ayele A. Assessment of drug use pattern by using WHO core drug use indicators at public hospitals in Ethiopia. Journal of Community Medicine & Health Education. 2017;7(5).

Anindhita A, Ardhaninggar A, Hidayati AN. Resistensi obat multipel pada gonore (Multidrug Resistant Gonorrhoeae). Majalah Kedokteran Indonesia. 2017;67(10):559–62.

Raini M. Antibiotik golongan fluorokuinolon: manfaat dan kerugian. Media Litbangkes. 2016;26(3):163–74.

Published
2021-08-31
How to Cite
1.
Handayani R, Sari I, Prihartini N, Yuniar Y, Gitawati R. Pola Peresepan Anak dengan Infeksi Saluran Pernapasan Akut (ISPA) Non Pneumonia di Klinik. jki [Internet]. 31Aug.2021 [cited 26May2022];11(2):156-64. Available from: https://ejournal2.litbang.kemkes.go.id/index.php/jki/article/view/4734